Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | FDPS | P14324 | 5/20 | 0.43 |
| ▸ | FFAR4 | Q5NUL3 | 1/20 | 0.41 |
| ▸ | FFAR1 | O14842 | 1/20 | 0.41 |
| ▸ | NFKB1 | P19838 | 1/20 | 0.39 |
| ▸ | GPR84 | Q9NQS5 | 5/20 | 0.38 |
| ▸ | CA1 | P00915 | 1/20 | 0.38 |
| ▸ | CA2 | P00918 | 1/20 | 0.38 |
| ▸ | USP2 | O75604 | 1/20 | 0.36 |
| ▸ | HTT | P42858 | 1/20 | 0.35 |
| ▸ | HTR1A | P08908 | 1/20 | 0.35 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.34 |
| ▸ | LPAR5 | Q9H1C0 | 1/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5162531 | 1.00 | FDPS (0.43) | FDPSFFAR4FFAR1NFKB1GPR84 | |
| SCHEMBL5158990 | 1.00 | FDPS (0.43) | FDPSFFAR4FFAR1NFKB1GPR84 | |
| SCHEMBL19114562 | 0.91 | FFAR4 (0.52) | FDPSFFAR4FFAR1NFKB1GPR84 | |
| SCHEMBL9629393 | 0.91 | FDPS (0.43) | FDPSFFAR4FFAR1NFKB1GPR84 | |
| SCHEMBL9629607 | 0.86 | FFAR4 (0.47) | FDPSFFAR4FFAR1NFKB1GPR84 | |
| SCHEMBL17233052 | 0.85 | — | — | |
| SCHEMBL13122621 | 0.84 | MAPT (0.31) | — | |
| SCHEMBL1521343 | 0.83 | — | — | |
| SCHEMBL8459834 | 0.82 | FFAR4 (0.52) | FDPSFFAR4FFAR1NFKB1GPR84 | |
| SCHEMBL18885426 | 0.82 | FFAR4 (0.52) | FDPSFFAR4FFAR1NFKB1GPR84 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1249446-B1 | Use of thio derivates as flavoring ingredients | FIRMENICH & CIE (CH) | 2007-03-07 | — | — | EP | disclosed |
| US-7008919-B2 | Use of thio derivatives as perfuming and flavoring ingredients | FIRMENICH SA (CH) | 2006-03-07 | — | — | US | disclosed |
| US-20030040460-A1 | Use of thio derivatives as perfuming and flavoring ingredients | FIRMENICH SA (CH) | 2003-02-27 | — | — | US | disclosed |
| EP-1249446-A2 | Use of thio derivates as perfuming and flavoring ingredients | FIRMENICH SA (CH) | 2002-10-16 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20030040460-A1 | Use of thio derivatives as perfuming and flavoring ingredients | TAS2R1, TAS2R4, TAS1R1 | FDPS 576/4885FFAR4 1019/4885FFAR1 998/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.